⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BNTX News
BioNTech SE American Depositary Share
OncoC4 Appoints Dr. Steve Chen, JD, PhD as General Counsel
prnewswire.com
BNTX
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
businesswire.com
BNTX
PFE
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
globenewswire.com
PFE
BNTX
Breast Cancer Continues to Impact Communities; Northwest Ohio Rallies Together to Take Action at Susan G. Komen ® Race for the Cure
businesswire.com
AMZN
LLY
GH
BNTX
BAC
NTRA
Global mRNA Cancer Vaccines Market Report 2026-2031: Assesses More Than 70 Vaccines Through Phase III
globenewswire.com
BNTX
MRNA
CVAC
TRNS
mRNA Therapeutics Market Outlook Report 2026-2035 Featuring Profiles of Arcturus Therapeutics, BioNTech, CureVac, Moderna, Providence Therapeutics, RNAimmune, Recode Therapeutics, and More
globenewswire.com
ARCT
BNTX
MRNA
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
globenewswire.com
SBFM
BNTX
AZN
MRNA
BMY
Workato Launches Otto for Everyone, AI Superagents That Run Whole Projects Start to Finish
businesswire.com
AMZN
CSCO
NVDA
GOOG
MSFT
IBM
ORCL
CRM
INTC
AMD
MU
QCOM
AAPL
META
NFLX
GOOGL
AMPL
SPCE
TSLA
BNTX
CRSP
EDIT
GILD
MRNA
REGN
VRTX
BIIB
AMGN
NCLH
CCL
RCL
XOM
CVX
SHEL
T
VZ
TMUS
NKE
DIS
MCD
KO
PEP
WMT
HD
JNJ
PG
UNH
MA
V
BOX
SHOP
Global RNAi Technology Market is Expected to Showcase Significant Growth at a CAGR of ~14% by 2034 | DelveInsight
globenewswire.com
BNTX
MRNA
DVAX
ALNY
BIIB
IONS
ARCT
VRTX
PFE
SGMO
AZN
CAT
TMO
LH
BreakBio, the Third Player in Personalized Drugs, Enters the Clinic
prnewswire.com
MRNA
BNTX